This brand name is authorized in New Zealand, Turkey
The drug SPAZMOL contains one active pharmaceutical ingredient (API):
|
1
Butylscopolamine
UNII 0GH9JX37C8 - BUTYLSCOPOLAMINE BROMIDE
|
|
Butylscopolamine is an antispasmodic agent which relaxes smooth muscle of the organs of the abdominal and pelvic cavities. It is believed to act predominantly on the intramural parasympathetic ganglia of these organs. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A03BB01 | Butylscopolamine | A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03B BELLADONNA AND DERIVATIVES, PLAIN → A03BB Belladonna alkaloids, semisynthetic, quaternary ammonium compounds |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 18067 |
| Country: TR | ฤฐlaรง ve Tฤฑbbi Cihaz Kurumu | Identifier(s): 8699525752413, 8699525759726 |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
